Botanical species · safety record

Senna alexandrina

The EFSA Compendium of Botanicals holds 4 constituent measurements and 3 adverse-effect records for Senna alexandrina. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Senna alexandrina Mill.

4Constituent measurements
3Safety records
5Cited sources
449Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 449 licensed products naming Senna alexandrina as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA

Source material stated

  • Aged bark
  • Dried fruit
  • Dried leaf
  • Dried leaflet
  • Dried leaflets
  • Fruit
  • Fruit and leaf
  • Fruit(s)

What the records describe

Constituents measured

  • 1,8-cineole1
  • Aloe-emodin1
  • Sennoside a1
  • Sennoside b1

Plant parts

  • Fruit unspecified3
  • Seed2
  • Leaves1
  • Unspecified1

Preparations

  • Solvent extraction5
  • Fresh2

Effect types

  • Systemic2
  • Hepatotoxicity1

Target tissues

  • Liver1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
1,8-cineoleLeavesSolvent extraction26.55 Percent AreaGC-MSResolve DOI
Aloe-emodinUnspecifiedSolvent extractionUnspecifiedResolve DOI
Sennoside aSeedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Sennoside bSeedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityLiverFruit unspecifiedSolvent extractionHuman (as organism)Case reportResolve DOI
SystemicFruit unspecifiedFreshGallus gallus (chicken) (as animal)SubchronicNo resolvable identifier
SystemicFruit unspecifiedFreshGallus gallus (chicken) (as animal)SubchronicNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Derbalah, Aly S. Efficacy of some botanical extracts against Trogoderma granarium in wheat grains with toxicity evaluation. . Thescientificworldjournal, 2012, vol. 2012, p. 639854-639854. DOI
  2. Kapadia, Govind J., Khorana, M. L. Paper chromatographic separation of sennoside A and sennoside B. Journal of Chromatography, 1961, p. 537-538.
  3. Omer, Sawsan A., Al-Olayan, Ebtesam M., El-Amin, Maha H., Hassan, Zeinab K., Daghestani, Maha H., Mohammed, Osama B. Experimental Cassia senna intoxication in Lohmann broiler chicks. Journal of Medicinal Plants Research, 2012, p. 3306-3310.
  4. Vanderperren, B., Rizzo, M., Angenot, L., Haufroid, V., Jadoul, M., Hantson, P. Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. ANNALS OF PHARMACOTHERAPY, 2005, vol. 39, no. 7-8, p. 1353-1357. DOI
  5. Zhou, J., Ouedraogo, M., Qu, F., Duez, P. Potential genotoxicity of traditional Chinese medicinal plants and phytochemicals: An overview. Phytotherapy Research, 2013, vol. 27, no. 12, p. 1745-1755. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue